Dolby Laboratories Inc Insider Trading
Every director, officer and 10% holder of Dolby Laboratories Inc has to report each trade in its stock within two business days of making it. This is those filings.
DLB on carbonthat →Purchases and sales
Open-market trades only — the lines where someone chose to buy or sell at the going price.
| Insider | Action | Value |
|---|---|---|
| John D CoulingSVP, Entertainment2026-10-016.8K shat $58.72 | Sale10b5-1 plan | $401.1K |
| John D CoulingSVP, Entertainment2026-10-01836 shat $59.33 | Sale10b5-1 plan | $49.6K |
| John D CoulingSVP, Entertainment2026-09-017.7K shat $61.05 | Sale10b5-1 plan | $468K |
| Ryan NicholsonVP, CAO and Corp. Controller2026-08-251.2K shat $65.28 | Sale | $77.2K |
| Shriram RevankarSVP, Advanced Technology Group2026-08-143K shat $62.71 | Sale10b5-1 plan | $188.1K |
| Ryan NicholsonVP, CAO and Corp. Controller2026-08-101.3K shat $62.04 | Sale | $83.6K |
| Ryan NicholsonVP, CAO and Corp. Controller2026-08-04357 shat $60.63 | Sale | $21.6K |
| John D CoulingSVP, Entertainment2026-08-03783 shat $59.03 | Sale10b5-1 plan | $46.2K |
| John D CoulingSVP, Entertainment2026-08-036.9K shat $60.11 | Sale10b5-1 plan | $413.8K |
| John D CoulingSVP, Entertainment2026-07-017.7K shat $53.20 | Sale10b5-1 plan | $407.9K |
Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
More on DLB
Follow Dolby Laboratories Inc (DLB) by email
New trades in Dolby Laboratories Inc (DLB) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.